Accounting and Finance BSc (Hons)

University of Warwick

**Why Warwick?**The University of Warwick is a world-leading university, born out of boldness, imagination and collaboration. We’ve built a strong reputation for upholding the highest academic and research standards.Today, more than 27,000 students thrive in a supportive, welcoming space where everything you need to study, live and have fun is close to hand. Explore what Warwick has to offer, and you’ll develop a skillset that sets you apart, and sets you up to succeed. What that success looks like is up to you.**The course**Our professionally orientated Accountancy and Finance degree is consistently ranked highly in major UK league tables. You will gain the skills, knowledge and confidence to operate effectively in the fast-paced world of multinational companies and global financial markets.You will be encouraged from the outset to think critically, enabling you to analyse and interpret real-life business issues in order to devise solutions, helping to prepare you for your career in accountancy, financial services, or management.You will also have the opportunity to develop your interpersonal skills including communication, leadership and teamworking, to become more adaptable and resilient to change. You will be taught by leading academics who are well connected with industry and able to combine cutting-edge theory with real-world practice.We have well-established links with accountancy firms, investment banks and renowned national and international employers such as JP Morgan and EY.In your final year, the module Critical Issues in Management will enable you to integrate what you have learned throughout your studies, enhance your knowledge through the introduction of new concepts, and apply your skills to a range of real-life case studies.If you choose our 4-year degree you will work in the UK or overseas. You may also apply for a study placement at one of our partner institutions. Previous work placements have been carried out at companies such as L’Oreal, Microsoft, EY, Goldman Sachs, and GlaxoSmithKline.